There is currently a lack of consensus and uncertainty about whether one should adjust for multiple testing in multi-arm trials of distinct treatments. A detailed rationale is presented to justify non-adjustment in this situation. We argue that non-adjustment should be the default starting position in simple multi-arm trials of distinct treatments.
FingerprintDive into the research topics of 'Non-adjustment for multiple testing in multi-arm trials of distinct treatments: rationale and justification'. Together they form a unique fingerprint.
- Deanery of Molecular, Genetic and Population Health Sciences - Senior Statistician
- Edinburgh Clinical Trials Unit
- Usher Institute
- Centre for Population Health Sciences
Person: Academic: Research Active